Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer-Reference-Cited by-同舟云学术

Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer

Published:2021-05-19 Issue: Volume: Page:
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Bilich Tatjana^ORCID,Roerden Malte^ORCID,Maringer Yacine^ORCID,Nelde Annika^ORCID,Heitmann Jonas S.,Dubbelaar Marissa L.^ORCID,Peter Andreas,Hörber Sebastian^ORCID,Bauer Jens,Rieth Jonas,Wacker Marcel^ORCID,Berner Fiamma,Flatz Lukas,Held Stefanie,Brossart Peter,Märklin Melanie^ORCID,Wagner Philipp,Erne Eva,Klein Reinhild^ORCID,Rammensee Hans-Georg,Salih Helmut R.^ORCID,Walz Juliane S.

Funder

German Cancer Consortium DKTK

Fortuene Program of the University of Tuebingen

Deutsche Forschungsgemeinschaft

Bundesministerium für Bildung und Forschung

Wilhelm Sander-Stiftung

José Carreras Leukämie-Stiftung

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

2. Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response;Vaccines;2024-08-01

3. Profile and Outcomes of COVID-19 Infection in Pediatric Patients with and without Cancer: A Case–Control Study;Indian Journal of Medical and Paediatric Oncology;2024-05-13

4. Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era;Frontiers in Oncology;2024-04-23

5. Decoding Immuno-Competence: A Novel Analysis of Complete Blood Cell Count Data in COVID-19 Outcomes;Biomedicines;2024-04-15